Showing items 1 - 2 of 2

Your selections:

Novel partial 5HT3 agonist pumosetrag reduces acid reflux events in uninvestigated GERD patients after a standard refluxogenic meal: a randomized, double-blind, placebo-controlled pharmacodynamic study

- Choung, R. S., Locke III, G. R., Talley, N. J., Francis, D. D., Katzka, D., Winkle, P. J., Orr, W. C., Crowell, M. D., Devault, K., Harmsen, W. S., Zinsmeister, A. R.

Functional dyspepsia: the economic impact to patients

- Lacy, B. E., Weiser, K. T., Kennedy, A. T., Crowell, M. D., Talley, N. J.

  • 1
  • Disclaimer
  • Privacy
  • Copyright
  • Contact
  • Deposit